The protease inhibitor PI*S allele and COPD: A meta-analysis

M. Dahl, C. P. Hersh, N. P. Ly, C. S. Berkey, E. K. Silverman, B. G. Nordestgaard

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstrakt

    In many countries, the protease inhibitor (SERPINA1) PI*S allele is more common than PI*Z, the allele responsible for most cases of chronic obstructive pulmonary disease (COPD) due to severe alpha 1-antitrypsin deficiency. However, the risk of COPD due to the PI*S allele is not clear. The current authors located studies that addressed the risk of COPD or measured lung function in individuals with the PI SZ, PI MS and PI SS genotypes. A separate meta-analysis for each genotype was performed. Aggregating data from six studies, the odds ratio (OR) for COPD in PI SZ compound heterozygotes compared with PI MM (normal) individuals was significantly increased at 3.26 (95% confidence intervals (CI): 1.24-8.57). In 17 cross-sectional and case-control studies, the OR for COPD in PI MS heterozygotes was 1.19 (95%CI: 1.02-1.38). However, PI MS genotype was not associated with COPD risk after correcting for smoking. Furthermore, mean forced expiratory volume in one second, a measure of airflow obstruction and a defining feature of COPD, did not differ between PI MS and PI MM individuals. There were not enough cases to summarise the risk of COPD in PI SS homozygotes. In conclusion, the results show that the PI SZ genotype is a significant risk factor for chronic obstructive pulmonary disease. The risk of chronic obstructive pulmonary disease due to the PI MS genotype is not substantially elevated.

    OriginalsprogEngelsk
    Sider (fra-til)67-76
    Antal sider10
    TidsskriftEuropean Respiratory Journal
    Vol/bind26
    Udgave nummer1
    DOI
    StatusUdgivet - 1 jul. 2005

    Fingeraftryk

    Udforsk hvilke forskningsemner 'The protease inhibitor PI*S allele and COPD: A meta-analysis' indeholder.

    Citationsformater